• High-Throughput BBB Modeling: Integrating MDR1 Cells and Lys

  2026-04-22

  This study introduces a robust, high-throughput in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK and LLC-PK1-MDR1 cells, enhanced by lysosomal trapping correction. The model demonstrates high predictive accuracy for CNS drug permeability and offers a scalable tool for early-stage neuropharmaceutical research.

• Tankyrase Inhibition Suppresses HCC Growth via Hippo Pathway

  2026-04-22

  This article examines how selective tankyrase 1/2 inhibitors, including G007-LK, suppress hepatocellular carcinoma (HCC) cell proliferation through modulation of the Hippo-YAP signaling cascade. The study provides mechanistic insight into the stabilization of YAP negative regulators, highlighting therapeutic potential for targeted interventions in liver cancer.

• Prestained Protein Marker (Triple color, EDTA free, 10-250 k

  2026-04-21

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) addresses the need for reliable, visible molecular weight standards in SDS-PAGE and Western blot workflows, especially where EDTA sensitivity or fluorescent membrane imaging is required. It should be used in workflows needing clear size verification and transfer assessment but is not intended for quantification or domains lacking color-dye compatibility.

• Z-VEID-FMK: Precision Caspase-6 Inhibitor for Apoptosis Assa

  2026-04-21

  Z-VEID-FMK empowers researchers to dissect caspase-6-dependent apoptotic pathways with unmatched specificity and workflow flexibility. Its irreversible inhibition and robust cell permeability make it a gold-standard tool in neuronal apoptosis research, cancer models, and advanced apoptosis assays.

• Epinephrine Concentrations in Local Anesthesia: Systemic and

  2026-04-20

  This review examines the systemic effects and optimal concentrations of epinephrine when used as a vasoconstrictor in local anesthesia for dental procedures. It highlights how appropriate dosing balances anesthetic efficacy, safety, and hemostasis, informing best practices for both clinical and research applications.

• SU 5402: Strategic RTK Inhibition for Translational Research

  2026-04-20

  This thought-leadership article provides translational researchers with a mechanistic and strategic roadmap for leveraging SU 5402 in receptor tyrosine kinase (RTK) pathway studies, cancer biology, and the emerging field of neuron-based disease modeling. Anchored in recent advances—including human iPSC-derived neuron models for HSV-1 latency—this article blends actionable protocol guidance with critical evaluation of SU 5402’s competitive positioning, experimental reproducibility, and future research potential. Evidence is rigorously cited, and APExBIO’s product provenance is highlighted, while internal links to related content further contextualize the discussion.

• Pulchinenoside B4 Targets CD1d/NLRP3 to Alleviate Colitis

  2026-04-19

  This study demonstrates that Pulchinenoside B4 (PB4) alleviates DSS-induced colitis by suppressing CD1d-dependent NLRP3 inflammasome activation in macrophages, offering a mechanistic advance in inflammation research. The work clarifies that PB4 operates via the AKT-STAT1-PRDX1-NF-κB pathway and highlights the role of myeloid CD1d in controlling inflammasome-driven pathology, paving the way for novel anti-colitis interventions.

• Ceapin-A7: Advanced Control of ER Stress Pathways in Cellula

  2026-04-18

  Ceapin-A7 is a selective ER stress blocker that enables precise modulation of the ATF6α pathway. This article delivers a deep, practical analysis of Ceapin-A7’s mechanism, research applications, and how recent findings reframe its use in disease-relevant cell models.

• Mechanistic Mastery: EZ Cap EGFP mRNA 5-moUTP in Translation

  2026-04-17

  This thought-leadership article unpacks the mechanistic advances and strategic applications of EZ Cap™ EGFP mRNA (5-moUTP) for translational researchers. It contextualizes the product’s Cap 1 structure and 5-methoxyuridine modifications within emerging trends in mRNA delivery, immune evasion, and tissue-targeted gene expression, referencing current literature and highlighting actionable guidance for experimental design and protocol optimization.

• Adefovir (GS-0393): Applied Protocols for HBV Antiviral Rese

  2026-04-16

  Adefovir (GS-0393) stands out as a highly selective HBV DNA polymerase inhibitor, enabling reproducible antiviral and transporter assays. This guide provides workflow-specific parameters, troubleshooting strategies, and expert insights to maximize research reliability with APExBIO’s Adefovir.

• Catalpol Mitigates Sepsis-Induced Cognitive Impairment via N

  2026-04-15

  This study demonstrates that Catalpol alleviates septic-associated encephalopathy in mice by concurrently inhibiting NF-κB-driven neuroinflammation and activating TrkB-mediated BDNF signaling. The findings clarify Catalpol’s dual mechanistic action and provide a basis for its use in translational neuroprotection research.

• Cholecystokinin Octapeptide Ammonium: Neuroprotection, Synap

  2026-04-14

  Explore how Cholecystokinin octapeptide ammonium (CCK-8 ammonium) advances neuroprotection and synaptic plasticity research. This in-depth article uniquely connects molecular mechanisms, translational assay design, and critical insights for optimizing experimental outcomes.

• Anti Reverse Cap Analog for Enhanced mRNA Translation Effici

  2026-04-13

  Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, offers superior orientation-specific capping for synthetic mRNA, nearly doubling translation efficiency and optimizing protein output for advanced research and therapeutic applications. This article delivers actionable workflow guidance, troubleshooting strategies, and connects recent neurotherapeutic breakthroughs with practical mRNA manufacturing decisions.

• 2-NBDG: Advanced Workflows for Fluorescent Glucose Uptake As

  2026-04-13

  2-NBDG, or 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose, enables rapid, quantitative, and real-time analysis of cellular glucose uptake. This article delivers stepwise protocols, troubleshooting strategies, and insights from cutting-edge tauopathy research, empowering metabolic and neurodegeneration studies with APExBIO’s 2-NBDG.

• Aurora A Kinase Regulates Trained Immunity via SAM Metabolis

  2026-04-12

  Li et al. (2025) reveal that Aurora kinase A (AurA) is essential for the establishment of trained immunity in innate immune cells by maintaining endogenous S-adenosylmethionine (SAM) levels through the mTOR–FOXO3–GNMT axis. Their integrative multiomic and functional analyses demonstrate that AurA inhibition impairs chromatin accessibility and methylation-dependent transcription of inflammatory genes, with direct implications for cancer immunology and translational research.

15203 records 1/1014 page Next 12345 下5页 Last page